12 -6 (92) 2026 - B. Sharipova - MULTIPLE MORPHOMETRIC INDICATORS OF THE PANSUM IN COVID-19-ASSOCIATED DIABETES

MULTIPLE MORPHOMETRIC INDICATORS OF THE PANSUM IN COVID-19-ASSOCIATED DIABETES

B. Sharipova - Tashkent State Medical University

Resume

Histomorphometry of all structural structures of the pancreas in patients infected with COVID-19, based on a number of numerical data, shows a sharp increase in age-related sclerotic and trophic changes. This confirms that in the covid-19 infection, the functional areas of the pancreas increase by 1.4-2.4 times compared to the control group, and the main changes are atrophic and sclerotic changes. Morphometric studies showed that the size of the pancreatic acinar structures, the size of the islets of Lwangerhans, and the area occupied by the stromal components increased compared to the control group.

Keywords: Covid-19, pancreas, morphometry, confocal imaging.

First page

58

Last page

67

For citation:B. Sharipova - MULTIPLE MORPHOMETRIC INDICATORS OF THE PANSUM IN COVID-19-ASSOCIATED DIABETES//New Day in Medicine 6(92)2026 58-67 https://newdayworldmedicine.com/en/new_day_medicine/6-92-2026

List of References

  1. Correia de Sá T, Soares C, Rocha M. Acute pancreatitis and COVID-19: a literature review. World J Gastrointest Surg. 2021;13(6):574-584. doi:10.4240/wjgs.v13.i6.574.
  2. Jabłońska B, Olakowski M, Mrowiec S. Association between acute pancreatitis and COVID-19 infection: what do we know? World J Gastrointest Surg. 2021;13(6):548-562. doi:10.4240/wjgs.v13.i6.548.
  3. Kusmartseva I, Wu W, Syed F, Van Der Heide V, Jorgensen M, Joseph P, et al. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 2020;32(6):1041-1051.e6. doi:10.1016/j.cmet.2020.11.005.
  4. Coate KC, Cha J, Shrestha S, Wang W, Gonçalves LM, Almaca J, et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in β cells. Cell Metab. 2020;32(6):1028-1040.e4. doi:10.1016/j.cmet.2020.11.006.
  5. Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health. 2021;8(4):720-742. doi:10.3934/publichealth.2021057.
  6. Goyal H, Kopel J, Ristić B, Perisetti A, Anastasiou J, Chandan S, et al. The pancreas and COVID-19: a clinical conundrum. Am J Transl Res. 2021;13(10):11004-11013.
  7. Pandanaboyana S, Moir J, Leeds JS, Oppong K, Kanwar A, Marzook H, et al. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study. Gut. 2021;70(6):1061-1069. doi:10.1136/gutjnl-2020-323364.
  8. Bacaksız F, Ebik B, Ekin N, Kılıç J. Pancreatic damage in COVID-19: Why? How? Int J Clin Pract. 2021;75(10):e14692. doi:10.1111/ijcp.14692.
  9. Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18(9):2128-2130.e2. doi:10.1016/j.cgh.2020.04.040.
  10. Bruno G, Fabrizio C, Santoro CR, Buccoliero GB. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence. J Med Virol. 2021;93(1):74-75. doi:10.1002/jmv.26134.

    file

    download